Fiscal Year Ending February 2027 – Second Quarter (Interim) Financial Summary [Japanese GAAP] (Consolidated)

Overview of Results

For the second quarter of the fiscal year ending February 2027, consolidated results showed net sales in the 49.9 billion yen range, a decrease of 5.9% year-over-year, while operating income improved to approximately 680 million yen, up 14.1%, and ordinary income improved to approximately 790 million yen, up 21.7%, indicating profitability improvements. By segment, supermarkets recorded net sales of 43,184 million yen, down 7.0% year-over-year. Drugstores were steady with net sales of 6,757 million yen, up 2.0%. Overall, despite pressures from higher raw material and logistics costs and inflation, the company continues structural reforms aimed at improving profitability.

Full-Year Outlook and Financial Position

At the end of the interim period, total assets stood at 50,258 million yen and the equity ratio remained healthy at 54.5%. Cash and cash equivalents decreased to the 3.8 billion yen range. The full-year earnings forecast has been revised from the previously announced figures; please refer to the disclosed materials for the full-year outlook. Dividend-related matters are TBD, but the most recent dividend forecast remains unchanged.